MXPA02002043A - Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive. - Google Patents

Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive.

Info

Publication number
MXPA02002043A
MXPA02002043A MXPA02002043A MXPA02002043A MXPA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A MX PA02002043 A MXPA02002043 A MX PA02002043A
Authority
MX
Mexico
Prior art keywords
drospirenone
ethinylestradiol
contraceptive
pharmaceutical combination
pharmaceutical
Prior art date
Application number
MXPA02002043A
Other languages
Spanish (es)
Inventor
Heil Wolfgang
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA02002043(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Publication of MXPA02002043A publication Critical patent/MXPA02002043A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MXPA02002043A 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive. MXPA02002043A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (1)

Publication Number Publication Date
MXPA02002043A true MXPA02002043A (en) 2003-08-20

Family

ID=26153358

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02002043A MXPA02002043A (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive.

Country Status (11)

Country Link
CN (1) CN1223350C (en)
BG (2) BG109749A (en)
CA (1) CA2382426C (en)
EE (1) EE05317B1 (en)
HR (1) HRP20020258B1 (en)
IL (2) IL197396A (en)
MX (1) MXPA02002043A (en)
NO (3) NO327588B3 (en)
RU (4) RU2269342C9 (en)
SK (1) SK287634B6 (en)
UA (1) UA81387C2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (en) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013078422A2 (en) 2011-11-23 2013-05-30 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RU2618471C2 (en) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Oral pharmaceutical composition of diuretics and ace inhibitor in micronized form, drug and its application
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015179782A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN108606963B (en) * 2017-12-27 2021-05-18 上海长海医院 Compound contraceptive patch containing drospirenone and estrogen, preparation method and application
CN111529482A (en) * 2020-05-20 2020-08-14 祝培 Testosterone undecanoate sustained-release implant and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (en) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them
DE4344462C2 (en) * 1993-12-22 1996-02-01 Schering Ag Composition for contraception
DE4411585A1 (en) * 1994-03-30 1995-10-05 Schering Ag Combined pharmaceutical preparation for hormonal contraception
ATE271386T1 (en) * 1996-07-26 2004-08-15 Wyeth Corp ORAL SINGLE STAGE CONTRACEPTION METHOD AND COMBINATION PRODUCT CONTAINING PROGESTEN AND ESTROGEN

Also Published As

Publication number Publication date
NO20091809L (en) 2002-04-26
RU2449796C9 (en) 2007-10-27
SK287634B6 (en) 2011-04-05
SK2572002A3 (en) 2002-11-06
NO20083854L (en) 2002-04-26
NO327588B3 (en) 2011-05-16
BG109749A (en) 2008-06-30
CA2382426C (en) 2006-02-28
NO2010004I1 (en) 2010-03-22
RU2396082C2 (en) 2010-08-10
CA2382426A1 (en) 2001-03-08
RU2269342C9 (en) 2007-10-27
HRP20020258B1 (en) 2007-05-31
RU2269342C2 (en) 2006-02-10
BG65204B1 (en) 2007-07-31
RU2005131868A (en) 2007-04-20
EE05317B1 (en) 2010-08-16
IL197396A (en) 2010-04-29
EE200900049A (en) 2009-10-15
HRP20020258A2 (en) 2005-02-28
BG106533A (en) 2002-10-31
IL200482A0 (en) 2011-07-31
UA81387C2 (en) 2008-01-10
RU2449796C2 (en) 2006-02-10
RU2010114825A (en) 2011-10-20
NO327588B1 (en) 2009-08-31
CN1407895A (en) 2003-04-02
RU2482853C2 (en) 2013-05-27
CN1223350C (en) 2005-10-19

Similar Documents

Publication Publication Date Title
HUP0202500A2 (en) Use of a pharmaceutical combination of ethinylestradiol and drospirenone for producing pharmaceutical compositions having contraceptive activity
IL200482A0 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
PL345955A1 (en) PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
IL152448A0 (en) 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same
HK1034455A1 (en) Oral pharmaceutical extended release dosage form.
IL145983A0 (en) Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof
HUP0200548A2 (en) Pharmaceutical compositions and their use
PL348113A1 (en) Drug delivery device, especially for the delivery of progestins and estrogens
HUP0400646A3 (en) Steroid hormone-compositions and processes for their preparation
IL154521A0 (en) Contraception process and administration form for the same
ZA9810136B (en) Anti-estrogen plus progestin containing oral contraceptives.
ZA200402458B (en) Estrogen/gestagen combination preparation and application thereof
HUP0301333A3 (en) Pharmaceutical superdisintegrant, process for its preparation and its use
AP2004003046A0 (en) Dosage regimen and pharmaceutical composition for emergency contraception.
HK1040055A1 (en) Use of olanzapine and fluoxetine in the preparation of a medicament for the treatment of treatment resistant major depression.
HK1046368A1 (en) Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
EP1236452A4 (en) Condom
AP2002002475A0 (en) Hormonal composition based on a progesterone and an oestrogen and use thereof
MXPA01011296A (en) Contraceptive compositions containing indoline derivatives and progestational agents.
HUP0201478A3 (en) Neuroprotective and retinoprotective ophthalmologic medicines
ZA200201668B (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive.
HUP0300128A3 (en) Male contraceptive composition comprising norethisterone and its use
HU0900070D0 (en) Use of a pharmaceutical combination of ethinylestradiol and drospirenone as a contraceptive

Legal Events

Date Code Title Description
FG Grant or registration
GD Licence granted
HC Change of company name or juridical status
HC Change of company name or juridical status